person · Reporting owner

TOKICH MICHAEL J

Disclosed activity across 4 companies

Tapewire entity: 46240
SEC CIK: 0001235611

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
METTLER TOLEDO INTERNATIONAL INC/MTD · Entity 3168	Director	February 17, 2026	February 19, 2026
STERIS plcSTE · Entity 3228	Sr. Vice Pres., CFO	June 04, 2025	June 06, 2025
TELEFLEX INCTFX · Entity 3798	Director	May 15, 2026	May 20, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

METTLER TOLEDO INTERNATIONAL INC/

Report date February 17, 2026 · Filed February 19, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common Stock, par value $0.01 per shareSEC Table I · non-derivative	Direct	50	Reported balance After 2026-02-17 transaction · row 1 1 source row Row 1 · 2026-02-17 · Grant · Acquired 50 · Balance 50
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1,353.24 · Expires 2036-02-17	Direct	130	Reported balance After 2026-02-17 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2026-02-17 · Grant · Acquired 130 · Balance 130 F1: The options vest annually in two equal installments beginning on the first anniversary of the date of grant.

Filing footnotes · ownership attribution and instrument terms

F1: The options vest annually in two equal installments beginning on the first anniversary of the date of grant.

STERIS plc

Report date June 04, 2025 · Filed June 06, 2025

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Ordinary SharesSEC Table I · non-derivative	Direct	43,891	Reported balance After 2025-06-04 transaction · row 1 Account or security details depend on footnotes; rows are not merged. 1 source row Row 1 · 2025-06-04 · Tax withholding · Disposed 341 · Balance 43,891 F1: 341 shares were withheld from the 1,141 restricted shares that vested on June 4, 2025. These 341 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 1,141 ordinary shares were awarded to Mr. Tokich on June 4, 2024. These vested shares were valued at the NYSE closing market price on June 4, 2025. F2: As of June 4, 2025, 6,506 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 144 on October 1, 2025; 1,293 on June 1, 2026; 564 on June 2, 2026; 741 on June 3, 2026; 1,141 on June 4, 2026; 741 on June 3, 2027; 1,141 on June 4, 2027 and 741 on June 5, 2028.
Ordinary SharesSEC Table I · non-derivative	IndirectSee Footnote Below	3,592	Reported balance Holding disclosure · report date 2025-06-04 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 3,592 F3: Units representing 3,592 ordinary share equivalents are held on behalf of the Reporting Person under the STERIS Corporation 401(k) Plan as of June 2, 2025.

Filing footnotes · ownership attribution and instrument terms

F1: 341 shares were withheld from the 1,141 restricted shares that vested on June 4, 2025. These 341 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 1,141 ordinary shares were awarded to Mr. Tokich on June 4, 2024. These vested shares were valued at the NYSE closing market price on June 4, 2025.

F2: As of June 4, 2025, 6,506 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 144 on October 1, 2025; 1,293 on June 1, 2026; 564 on June 2, 2026; 741 on June 3, 2026; 1,141 on June 4, 2026; 741 on June 3, 2027; 1,141 on June 4, 2027 and 741 on June 5, 2028.

F3: Units representing 3,592 ordinary share equivalents are held on behalf of the Reporting Person under the STERIS Corporation 401(k) Plan as of June 2, 2025.

TELEFLEX INC

Report date May 15, 2026 · Filed May 20, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	1,090	Reported balance After 2026-05-15 transaction · row 1 1 source row Row 1 · 2026-05-15 · Grant · Acquired 1,090 · Balance 1,090 F1: Restricted Stock Unit Award granted pursuant to the Teleflex Incorporated 2023 Stock Incentive Plan. Award vests 100% on the one-year anniversary of the grant date; provided, however, if the reporting person does not stand for re-election to the issuer's board of directors (the "Board") at the issuer's 2027 annual meeting of stockholders (the "2027 Annual Meeting"), the award will vest on the earlier of the one-year anniversary of the grant date and the date of the 2027 Annual Meeting, so long as such meeting is held at least 50 weeks after the issuer's 2026 annual meeting of stockholders (the "2026 Annual Meeting").
Stock Option / (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $129.71 · Expires 2036-05-15	Direct	4,793	Reported balance After 2026-05-15 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2026-05-15 · Grant · Acquired 4,793 · Balance 4,793 F2: Stock Option Award vests 100% on the one-year anniversary of the grant date; provided, however, if the reporting person does not stand for re-election to the Board at the 2027 Annual Meeting, the award will vest on the earlier of the one-year anniversary of the grant date and the date of the 2027 Annual Meeting, so long as such meeting is held at least 50 weeks after the 2026 Annual Meeting.

Filing footnotes · ownership attribution and instrument terms

F1: Restricted Stock Unit Award granted pursuant to the Teleflex Incorporated 2023 Stock Incentive Plan. Award vests 100% on the one-year anniversary of the grant date; provided, however, if the reporting person does not stand for re-election to the issuer's board of directors (the "Board") at the issuer's 2027 annual meeting of stockholders (the "2027 Annual Meeting"), the award will vest on the earlier of the one-year anniversary of the grant date and the date of the 2027 Annual Meeting, so long as such meeting is held at least 50 weeks after the issuer's 2026 annual meeting of stockholders (the "2026 Annual Meeting").

F2: Stock Option Award vests 100% on the one-year anniversary of the grant date; provided, however, if the reporting person does not stand for re-election to the Board at the 2027 Annual Meeting, the award will vest on the earlier of the one-year anniversary of the grant date and the date of the 2027 Annual Meeting, so long as such meeting is held at least 50 weeks after the 2026 Annual Meeting.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

STERIS plc

Report date March 28, 2019 · Filed March 28, 2019

Section 16 reporting ended · disclosed 2019-03-28. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Ordinary Shares, 10 pence par valueSEC Table I · non-derivative	Direct	Reported balance After 2019-03-28 transaction · row 1 1 source row Row 1 · 2019-03-28 · Disposition to issuer · Disposed 50,458 · Balance 0 F1: 25,940 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 7,000 on May 28, 2019; 4,000 on October 1, 2019; 4,700 on June 1, 2020; 6,000 on June 1, 2021; and 4,240 on May 31, 2022. F2: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS.
Ordinary Shares, 10 pence par valueSEC Table I · non-derivative	IndirectSee Footnote Below.	Reported balance After 2019-03-28 transaction · row 2 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 2 · 2019-03-28 · Disposition to issuer · Disposed 3,406 · Balance 0 F2: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. F3: Units representing 3,406 ordinary share equivalents are held on behalf of the Reporting Person under the STERIS Corporation 401(k) Plan as of March 27, 2019.
Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $45.34 · Expires 2023-05-31	Direct	Reported balance After 2019-03-28 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2019-03-28 · Disposition to issuer · Disposed 22,000 · Balance 0 F4: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 22,000 ordinary shares of STERIS for $45.34 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $53.52 · Expires 2024-05-30	Direct	Reported balance After 2019-03-28 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2019-03-28 · Disposition to issuer · Disposed 28,000 · Balance 0 F5: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 28,000 ordinary shares of STERIS for $53.52 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $67.98 · Expires 2025-08-10	Direct	Reported balance After 2019-03-28 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2019-03-28 · Disposition to issuer · Disposed 20,000 · Balance 0 F6: This option will become exercisable as follows: 5,000 on May 28, 2016; 5,000 on May 28, 2017; 5,000 on May 28, 2018 and 5,000 on May 28, 2019. This option was assumed by STERIS under the Scheme and converted to an option to purchase 20,000 ordinary shares of STERIS for $67.98 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $69.72 · Expires 2026-06-01	Direct	Reported balance After 2019-03-28 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2019-03-28 · Disposition to issuer · Disposed 30,000 · Balance 0 F7: This option becomes exercisable as follows: 7,500 on June 1, 2017; 7,500 on June 1, 2018; 7,500 on June 3, 2019 and 7,500 on June 1, 2020. This option was assumed by STERIS under the Scheme and converted to an option to purchase 30,000 ordinary shares of STERIS for $69.72 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $77.07 · Expires 2027-05-30	Direct	Reported balance After 2019-03-28 transaction · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · 2019-03-28 · Disposition to issuer · Disposed 32,000 · Balance 0 F8: This option becomes exercisable as follows: 8,000 on May 30, 2018; 8,000 on May 30, 2019; 8,000 on June 1, 2020 and 8,000 on June 1, 2021. This option was assumed by STERIS under the Scheme and converted to an option to purchase 32,000 ordinary shares of STERIS for $77.07 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $114.22 · Expires 2028-05-31	Direct	Reported balance After 2019-03-28 transaction · row 8 Instrument identity requires review; Table II rows are not merged. 1 source row Row 8 · 2019-03-28 · Disposition to issuer · Disposed 46,664 · Balance 0 F9: This option becomes exercisable as follows: 11,666 on May 31, 2019; 11,666 on June 1, 2020; 11,666 on June 1, 2021 and 11,666 on May 31, 2022. This option was assumed by STERIS under the Scheme and converted to an option to purchase 46,664 ordinary shares of STERIS for $114.22 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.

Filing footnotes · ownership attribution and instrument terms

F1: 25,940 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 7,000 on May 28, 2019; 4,000 on October 1, 2019; 4,700 on June 1, 2020; 6,000 on June 1, 2021; and 4,240 on May 31, 2022.

F2: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS.

F3: Units representing 3,406 ordinary share equivalents are held on behalf of the Reporting Person under the STERIS Corporation 401(k) Plan as of March 27, 2019.

F4: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 22,000 ordinary shares of STERIS for $45.34 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.

F5: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 28,000 ordinary shares of STERIS for $53.52 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.

F6: This option will become exercisable as follows: 5,000 on May 28, 2016; 5,000 on May 28, 2017; 5,000 on May 28, 2018 and 5,000 on May 28, 2019. This option was assumed by STERIS under the Scheme and converted to an option to purchase 20,000 ordinary shares of STERIS for $67.98 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.

F7: This option becomes exercisable as follows: 7,500 on June 1, 2017; 7,500 on June 1, 2018; 7,500 on June 3, 2019 and 7,500 on June 1, 2020. This option was assumed by STERIS under the Scheme and converted to an option to purchase 30,000 ordinary shares of STERIS for $69.72 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.

F8: This option becomes exercisable as follows: 8,000 on May 30, 2018; 8,000 on May 30, 2019; 8,000 on June 1, 2020 and 8,000 on June 1, 2021. This option was assumed by STERIS under the Scheme and converted to an option to purchase 32,000 ordinary shares of STERIS for $77.07 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.

F9: This option becomes exercisable as follows: 11,666 on May 31, 2019; 11,666 on June 1, 2020; 11,666 on June 1, 2021 and 11,666 on May 31, 2022. This option was assumed by STERIS under the Scheme and converted to an option to purchase 46,664 ordinary shares of STERIS for $114.22 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
May 30, 2018 Filed Jun 1, 2018 20:55 UTC	STERIS plc STE · Entity 158792	Tax withholdingOrdinary Shares, 10 pence par value	1,370	$104.57	$143,260.90	Disclosure SEC source: 0001209191-18-034745 · doc4.xml · nonDerivative · entry 1 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,218 F1 · shares: 1,370 shares were withheld from the 4,500 restricted shares that vested on May 30, 2018. These 1,370 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 4,500 shares were awarded to Mr. Tokich on May 30, 2014 as part of an award of 4,500 restricted shares. These vested shares were valued at the NYSE closing market price on May 30, 2018. Read SEC document
October 23, 2017 Filed Oct 24, 2017 20:34 UTC	STERIS plc STE · Entity 158792	Exercise / conversionEmployee Stock Option (right to buy) · Derivative	11,000	$0.00 Strike: $31.87	$0.00	Disclosure SEC source: 0001209191-17-057851 · doc4.xml · derivative · entry 4 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 11,000 shares Expires 2020-05-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option to purchase 11,000 STERIS plc ordinary shares, which is fully vested, was received in the Merger in exchange for an option to purchase 11,000 STERIS Corporation common shares for $31.87 per share, subject to the same terms and conditions as the original STERIS stock option. Read SEC document
October 23, 2017 Filed Oct 24, 2017 20:34 UTC	STERIS plc STE · Entity 158792	SaleOrdinary Shares, 10 pence par value	11,000	$92.00	$1,012,000.00	Disclosure SEC source: 0001209191-17-057851 · doc4.xml · nonDerivative · entry 2 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,588 F1 · shares: This exercise and sale of a total of 11,000 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on August 25, 2017. F2 · balance_after: 26,200 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,500 on May 30, 2018; 7,000 on May 28, 2019; 4,000 on October 1, 2019; 4,700 on June 1, 2020 and 6,000 on June 1, 2021. Read SEC document
October 23, 2017 Filed Oct 24, 2017 20:34 UTC	STERIS plc STE · Entity 158792	Exercise / conversionOrdinary Shares, 10 pence par value	11,000	$31.87	$350,570.00	Disclosure SEC source: 0001209191-17-057851 · doc4.xml · nonDerivative · entry 1 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,588 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This exercise and sale of a total of 11,000 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on August 25, 2017. Read SEC document
October 04, 2017 Filed Oct 6, 2017 20:37 UTC	STERIS plc STE · Entity 158792	Exercise / conversionEmployee Stock Option (right to buy) · Derivative	12,000	$0.00 Strike: $22.83	$0.00	Disclosure SEC source: 0001209191-17-056298 · doc4.xml · derivative · entry 4 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 12,000 shares Expires 2019-05-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option to purchase 12,000 STERIS plc ordinary shares, which is fully vested, was received in the Merger in exchange for an option to purchase 12,000 STERIS Corporation common shares for $22.83 per share, subject to the same terms and conditions as the original STERIS Corporation stock option. Read SEC document
October 04, 2017 Filed Oct 6, 2017 20:37 UTC	STERIS plc STE · Entity 158792	SaleOrdinary Shares, 10 pence par value	12,000	$89.75	$1,077,000.00	Disclosure SEC source: 0001209191-17-056298 · doc4.xml · nonDerivative · entry 2 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,588 F1 · shares: This exercise and sale of a total of 12,000 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on August 31, 2017. F2 · balance_after: 26,200 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,500 on May 30, 2018; 7,000 on May 28, 2019; 4,000 on October 1, 2019; 4,700 on June 1, 2020 and 6,000 on June 1, 2021. Read SEC document
October 04, 2017 Filed Oct 6, 2017 20:37 UTC	STERIS plc STE · Entity 158792	Exercise / conversionOrdinary Shares, 10 pence par value	12,000	$22.83	$273,960.00	Disclosure SEC source: 0001209191-17-056298 · doc4.xml · nonDerivative · entry 1 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,588 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This exercise and sale of a total of 12,000 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on August 31, 2017. Read SEC document
May 31, 2017 Filed Jun 1, 2017 20:46 UTC	STERIS plc STE · Entity 158792	Tax withholdingOrdinary Shares, 10 pence par value	2,918	$77.56	$226,320.08	Disclosure SEC source: 0001209191-17-036818 · doc4.xml · nonDerivative · entry 2 TOKICH MICHAEL J · CIK 0001235611 · SVP, CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,588 F2 · shares: 2,918 shares were withheld from the 7,000 restricted shares that vested on May 31, 2017. These 2,198 ordinary shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 7,000 ordinary shares were awarded to Mr. Tokich on May 30, 2013. These vested shares were valued at the NYSE closing market price on May 31, 2017. F3 · balance_after: 26,200 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,500 on May 30, 2018; 7,000 on May 28, 2019; 4,000 on October 1, 2019; 4,700 on June 1, 2020 and 6,000 on June 1, 2021. Read SEC document
May 30, 2017 Filed Jun 1, 2017 20:46 UTC	STERIS plc STE · Entity 158792	GrantEmployee Stock Option (right to buy) · Derivative	32,000	$0.00 Strike: $77.07	$0.00	Disclosure SEC source: 0001209191-17-036818 · doc4.xml · derivative · entry 4 TOKICH MICHAEL J · CIK 0001235611 · SVP, CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,000 Underlying: Ordinary Shares · 32,000 shares Expires 2027-05-30 F5 · derivative.exercise_date: This option becomes exercisable as follows: 8,000 on May 30, 2018; 8,000 on May 30, 2019; 8,000 on June 1, 2020 and 8,000 on June 1, 2021. Read SEC document
May 30, 2017 Filed Jun 1, 2017 20:46 UTC	STERIS plc STE · Entity 158792	GrantOrdinary Shares, 10 pence par value	6,000	$0.00	$0.00	Disclosure SEC source: 0001209191-17-036818 · doc4.xml · nonDerivative · entry 1 TOKICH MICHAEL J · CIK 0001235611 · SVP, CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,506 F1 · shares: All 6,000 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 6,000 on June 1, 2021. Read SEC document
May 09, 2017 Filed May 10, 2017 20:37 UTC	STERIS plc STE · Entity 158792	Exercise / conversionEmployee Stock Option (right to buy) · Derivative	13,600	$0.00 Strike: $26.41	$0.00	Disclosure SEC source: 0001209191-17-031310 · doc4.xml · derivative · entry 4 TOKICH MICHAEL J · CIK 0001235611 · SVP, CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 13,600 shares Expires 2018-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option to purchase 13,600 STERIS plc ordinary shares, which is fully vested, was received in the Merger in exchange for an option to purchase 13,600 STERIS Corporation common shares for $26.41 per share, subject to the same terms and conditions as the original STERIS Corporation stock option. Read SEC document
May 09, 2017 Filed May 10, 2017 20:37 UTC	STERIS plc STE · Entity 158792	SaleOrdinary Shares, 10 pence par value	13,600	$76.00	$1,033,600.00	Disclosure SEC source: 0001209191-17-031310 · doc4.xml · nonDerivative · entry 2 TOKICH MICHAEL J · CIK 0001235611 · SVP, CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,506 F2 · balance_after: 27,200 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 7,000 on May 31, 2017; 4,500 on May 30, 2018; 7,000 on May 28, 2019; 4,000 on October 1, 2019 and 4,700 on June 1, 2020. Read SEC document
May 09, 2017 Filed May 10, 2017 20:37 UTC	STERIS plc STE · Entity 158792	Exercise / conversionOrdinary Shares, 10 pence par value	13,600	$26.41	$359,176.00	Disclosure SEC source: 0001209191-17-031310 · doc4.xml · nonDerivative · entry 1 TOKICH MICHAEL J · CIK 0001235611 · SVP, CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,106 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This exercise and sale of a total of 13,600 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on November 28, 2016. Read SEC document
May 03, 2017 Filed May 5, 2017 20:42 UTC	STERIS plc STE · Entity 158792	Exercise / conversionEmployee Stock Option (right to buy) · Derivative	2,000	$0.00 Strike: $27.45	$0.00	Disclosure SEC source: 0001209191-17-030359 · doc4.xml · derivative · entry 4 TOKICH MICHAEL J · CIK 0001235611 · SVP, CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,000 shares Expires 2017-11-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option to purchase 2,000 STERIS plc ordinary shares, which is fully vested, was received in the Merger in exchange for an option to purchase 2,000 STERIS Corporation common shares for $27.45 per share, subject to the same terms and conditions as the original STERIS Corporation stock option. Read SEC document
May 03, 2017 Filed May 5, 2017 20:42 UTC	STERIS plc STE · Entity 158792	SaleOrdinary Shares, 10 pence par value	2,000	$75.00	$150,000.00	Disclosure SEC source: 0001209191-17-030359 · doc4.xml · nonDerivative · entry 2 TOKICH MICHAEL J · CIK 0001235611 · SVP, CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,506 F2 · balance_after: 27,200 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 7,000 on May 31, 2017; 4,500 on May 30, 2018; 7,000 on May 28, 2019; 4,700 on June 1, 2020 and 4,000 on October 1, 2020. Read SEC document
May 03, 2017 Filed May 5, 2017 20:42 UTC	STERIS plc STE · Entity 158792	Exercise / conversionOrdinary Shares, 10 pence par value	2,000	$27.45	$54,900.00	Disclosure SEC source: 0001209191-17-030359 · doc4.xml · nonDerivative · entry 1 TOKICH MICHAEL J · CIK 0001235611 · SVP, CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,506 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This exercise and sale of a total of 2,000 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on November 28, 2016. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.